CARCINOSARCOMA
Clinical trials for CARCINOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new CARCINOSARCOMA trials appear
Sign up with your email to follow new studies for CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for aggressive endometrial cancer: drug combo targets obesity link
Disease control Recruiting nowThis early-stage trial is testing the safety of combining two drugs, atezolizumab and ONC201, for people with advanced or recurrent endometrial cancer. The study includes both obese and non-obese participants to see how body weight affects treatment. The goal is to find the best …
Matched conditions: CARCINOSARCOMA
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:27 UTC
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: CARCINOSARCOMA
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
Massive sarcoma registry launches to unlock secrets of rare cancers
Knowledge-focused Recruiting nowThis study is a registry that will collect information from up to 9,000 people in Germany with sarcoma or carcinosarcoma. Researchers will track what treatments patients receive and how they do over time. The goal is to better understand these rare cancers, not to test a new trea…
Matched conditions: CARCINOSARCOMA
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC